Drugs / Praga formulation
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04666714 | May 2023 → Sep 2025 overdue | neuropathy, painful | EMS | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Praga formulation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04666714 ↗ |
| Route | Oral | “plus Praga formulation,oral” NCT04666714 ↗ |